Aldosterone deficiency II (CMO II deficiency) is not the result of a mutation of an MspI restriction site within the CYP11B gene
- 1 January 1991
- journal article
- research article
- Published by Springer Nature in Human Genetics
- Vol. 87 (1) , 97-98
- https://doi.org/10.1007/bf01213103
Abstract
We report our investigations of a German family with aldosterone deficiency (CMO II deficiency). Restriction fragment length polymorphism analysis using a P450c11 probe demonstrates that aMspI restriction site mutation within the CYP11B gene cannot be the underlying cause for this defect, as has been suggested previously.Keywords
This publication has 5 references indexed in Scilit:
- An Inherited Defect in Aldosterone Biosynthesis Caused by a Mutation in or near the Gene for Steroid 11-HydroxylaseNew England Journal of Medicine, 1988
- Cloning of cDNA encoding steroid 11 beta-hydroxylase (P450c11).Proceedings of the National Academy of Sciences, 1987
- The synthesis of aldosterone by the adrenal cortex. Two zones (fasciculata and glomerulosa) possess one enzyme for 11 beta-, 18-hydroxylation, and aldehyde synthesis.Journal of Biological Chemistry, 1986
- Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase IJournal of Molecular Biology, 1977
- Selective hypoaldosteronism in Iranian Jews: An autosomal recessive traitClinical Genetics, 1977